Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.

Berbers GA, van de Wetering MS, van Gageldonk PG, Schellekens JF, Versteegh FG, Teunis PF.

Vaccine. 2013 Aug 12;31(36):3732-8. doi: 10.1016/j.vaccine.2013.05.073.

PMID:
23742995
2.

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.

Cherry JD, Gornbein J, Heininger U, Stehr K.

Vaccine. 1998 Dec;16(20):1901-6.

PMID:
9796041
3.

Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers.

Littmann M, Hülsse C, Riffelmann M, Wirsing von König CH.

Vaccine. 2008 May 2;26(19):2344-9. doi: 10.1016/j.vaccine.2008.02.065.

PMID:
18396360
4.

Determination of pertactin IgG antibodies for the diagnosis of pertussis.

Trollfors B, Lagergård T, Gunnarsson E, Taranger J.

Clin Microbiol Infect. 2003 Jul;9(7):585-9.

5.

Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.

Dalby T, Petersen JW, Harboe ZB, Krogfelt KA.

J Med Microbiol. 2010 Sep;59(Pt 9):1029-36. doi: 10.1099/jmm.0.020826-0.

PMID:
20508003
6.
7.

Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.

Trollfors B, Taranger J, Lagergård T, Sundh V, Bryla DA, Schneerson R, Robbins JB.

Clin Infect Dis. 1999 Mar;28(3):552-9.

PMID:
10194077
8.

Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.

Cherry JD, Heininger U, Richards DM, Storsaeter J, Gustafsson L, Ljungman M, Hallander HO.

Clin Vaccine Immunol. 2010 May;17(5):741-7. doi: 10.1128/CVI.00469-09.

10.

A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.

Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD.

Pediatrics. 1997 Nov;100(5):772-88.

PMID:
9346976
11.

Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007.

Hallander H, Advani A, Alexander F, Gustafsson L, Ljungman M, Pratt C, Hall I, Gorringe AR.

Clin Vaccine Immunol. 2014 Feb;21(2):165-73. doi: 10.1128/CVI.00641-13.

12.

Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children.

Hendrikx LH, Schure RM, Oztürk K, de Rond LG, de Greeff SC, Sanders EA, Berbers GA, Buisman AM.

Vaccine. 2011 Sep 16;29(40):6874-80. doi: 10.1016/j.vaccine.2011.07.055.

PMID:
21803088
14.

Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates.

Annunziato PW, Rothstein EP, Bernstein HH, Blatter MM, Reisinger KS, Pichichero ME.

Arch Pediatr Adolesc Med. 1994 May;148(5):503-7.

PMID:
8180641
15.

Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.

Isacson J, Trollfors B, Hedvall G, Taranger J, Zackrisson G.

Scand J Infect Dis. 1995;27(3):273-7.

PMID:
8539553
16.

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.

Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi degli Atti ML, Giammanco A; Stage III Working Group..

Pediatrics. 2001 Nov;108(5):E81.

PMID:
11694665
17.

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.

Storsaeter J, Hallander HO, Gustafsson L, Olin P.

Vaccine. 1998 Dec;16(20):1907-16.

PMID:
9796042
18.

Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.

Stenger RM, Smits M, Kuipers B, van Gaans-van den Brink J, Poelen M, Boog CJ, van Els CA.

Vaccine. 2010 Sep 14;28(40):6637-46. doi: 10.1016/j.vaccine.2010.06.118.

PMID:
20637762
19.

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.

Hendrikx LH, Berbers GA, Veenhoven RH, Sanders EA, Buisman AM.

Vaccine. 2009 Nov 5;27(47):6530-6. doi: 10.1016/j.vaccine.2009.08.052.

PMID:
19729085
20.

Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.

Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A.

Dev Biol Stand. 1997;89:315-20.

PMID:
9272365

Supplemental Content

Support Center